Investors will get it. Company has 1000's of users of Tollovid to draw from which I assume many are in the standard-risk population category.
And this is Tollovid. Would Tollovir work even better in the standard-risk population? We shall see.
(1)
(0)
Todos Med Ltd. (TOMDF) Stock Research Links
-
-
-
-
-
-
-